Tenon Medical announced it will implement a 1-for-35 reverse stock split effective at 12:01 Eastern Time on August 10, 2026. The move is intended to raise the per-share trading price to meet Nasdaq's minimum $1.00 average closing price requirement for continued listing on the Nasdaq Capital Market. Shares will begin trading on a split-adjusted basis under the ticker symbol TNON with a new CUSIP number, and no fractional shares will be issued, with positions rounded up to the nearest whole share. The reverse split does not alter the company's fundamentals but is a mechanical adjustment to maintain compliance with Nasdaq listing requirements. Tenon Medical, based in Los Gatos, California, develops sacroiliac joint fusion systems including the Catamaran SI Joint Fusion System and SImmetry+ SI Joint Fusion System.
Tenon Medical IncReverse stock split is a mechanical adjustment to meet Nasdaq listing requirement, not a fundamental change.
